Oxford Immunotec
(OXFD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -906 | -1,496 | 120,779 | -20,281 | -16,797 |
| Depreciation Amortization | 800 | 470 | 4,070 | 1,374 | 937 |
| Income taxes - deferred | -1,518 | -279 | -38,760 | 1,117 | 728 |
| Accounts receivable | -4,695 | -900 | -3,390 | -1,291 | -986 |
| Accounts payable and accrued liabilities | -194 | 142 | -10,375 | -8,982 | -8,131 |
| Other Working Capital | -8,427 | -5,173 | -15,435 | -6,862 | -10,478 |
| Other Operating Activity | 6,712 | 1,662 | -89,008 | 14,011 | 14,681 |
| Operating Cash Flow | $-8,228 | $-5,574 | $-32,119 | $-20,914 | $-20,046 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -520 | -142 | -5,350 | -4,884 | -3,389 |
| Investing Cash Flow | $-520 | $-142 | $-5,350 | $-4,884 | $-3,389 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -60 | -57 | -38 |
| Common Stock Issued | 3,332 | 1,799 | 3,241 | 2,697 | 814 |
| Other Financing Activity | -155 | -145 | -32,488 | -265 | -265 |
| Financing Cash Flow | $3,177 | $1,654 | $-29,307 | $2,375 | $511 |
| Exchange Rate Effect | 18 | 736 | -1,711 | -994 | -436 |
| Beginning Cash Position | 192,944 | 192,944 | 90,532 | 90,532 | 90,532 |
| End Cash Position | 187,391 | 189,618 | 192,944 | 70,356 | 66,463 |
| Net Cash Flow | $-5,553 | $-3,326 | $102,412 | $-20,176 | $-24,069 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,228 | -5,574 | -32,119 | -20,914 | -20,046 |
| Capital Expenditure | -520 | -142 | -5,350 | -4,884 | -3,389 |
| Free Cash Flow | -8,748 | -5,716 | -37,469 | -25,798 | -23,435 |